in 48-well plates (5–10 × 103 per well) in
a complete medium containing Dulbecco’s modified Eagle’s
medium (DMEM, Sigma-Aldrich, #D6429) supplemented with 10% heat-inactivated
fetal bovine serum (FBS, Gibco, #1050064) and penicillin (100 U/mL)/streptomycin
(100 μg/mL) (Gibco, #15140122) in a humidified atmosphere at
37 °C with 5% CO2. At a confluency of ∼70%,
cells were treated with a medium containing 0.5 μM Bex, 12.5
μM Bex, or 0.5 μM XCT, 12.5 μM XCT or 0.5 μM
BRF110, 12.5 μM BRF110 for 24 h. Following treatment, total
RNA was isolated according to the RNeasy Mini Kit protocol (Qiagen,
Hilden, Germany) and cDNA was synthesized using the PrimeScript RT
reagent Kit (Takara, RR037A) using oligo-dT and random hexamers. Quantitative
PCR was performed in a 7500 Real-Time PCR System (Applied Biosystems,
Carlsbad, CA, USA) using 2× SYBR Select Master Mix (Applied Biosystems,
#4472918). Gene expression analysis was carried out using the 2–ΔΔCT relative quantification
method. Triplicate reactions were performed for each sample, and the
average CT was calculated for the quantification analysis. GAPDH was
used as an endogenous reference control. Human SREBP-1c (F, 5′-CCATGGATTGCACTTTCGAA-3′;
R, 5′-GGCCAGGGAAGTCACTGTCTT-3′). Human GAPDH (F, 5′-TGGGCTACACTGAGCACCAG-3′;
R, 5′-GGGTGTCGCTGTTGAAGTCA-3′).